Managing patients with antibodies to high- frequency antigens - our experience (CROSBI ID 692842)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Raos, Mirela ; Lukic, Marija ; Plenkovic, Fini ; Golubic Cepulic, Branka
engleski
Managing patients with antibodies to high- frequency antigens - our experience
An investigation of the antibody to a high- frequency antigen (HFA) is both very demanding and time consuming. Although some of the antibodies that are serologically difficult to identify are those with the least clinical significance (i.e. anti-Csa, -Ch, -Rg, -Yta, -JMH), many have been responsible for immediate HTR (i.g. anti-Vel, Inb), delayed HTR (i.g. anti-Kpb, - Jsb), severe HDFN (i.g. anti-k, anti-RH17) or mild HDFN (i.g. anti-K18) where antigen negative blood should be transfused. While HFA-negative subjects are excessively rare amongst white people, transfusion management in patients with HFA alloantibodies is often difficult.
Antibodies to high-frequency antigens
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
201-201.
2017.
objavljeno
Podaci o matičnoj publikaciji
Vox Sanguinis
Podaci o skupu
27th Regional Congress of the ISBT
poster
17.06.2017-21.06.2017
Kopenhagen, Danska